Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents

J. Saleh, J. E. Blevins, Peter J Havel, J. A. Barrett, D. W. Gietzen, K. Cianflone

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

BACKGROUND: In vitro studies have shown that acylation stimulating protein (ASP) stimulates triglyceride (TG) synthesis and storage in adipocytes. We have previously demonstrated that intraperitoneal (i.p.) injection of ASP in C57BL/6J mice accelerated TG clearance following an orally-administered fat load as well as reducing postprandial glucose levels. RESULTS: In the present study, we first examined the effect of i.p. and intracerebroventricular (i.c.v.) injection of ASP on food intake in Sprague - Dawley rats. Intraperitoneal injection resulted in a short-term increase in food intake (maximum increase 29.3% within the first hour, P < 0.025) decreasing thereafter as compared to vehicle alone, i.c.v. Administration of a comparable dose of ASP resulted in a similar but delayed increase in food intake with a maximum at 2 - 4 h, suggesting that the actions of ASP are peripherally mediated. However, there was no significant difference in 24 h food intake with either i.p. or i.c.v. injection. We also examined the effects of ASP on TG clearance in two obese mouse strains with different metabolic profiles: ob/ob (C57BL/6J-Lepob) and db/db (C57BLKS/J-Leprdb). In a crossover design, the response to an oral fat load was determined with and without i.p. injection of exogenous ASP. In ob/ob mice, there was a 44% greater clearance of postprandial TG (area under the curve (AUC) = 245±49 control vs 138±43 mg/dl h with ASP; P< 0.05 by RM ANOVA). The db/db mice showed a greater response, with a 62% decrease in postprandial TG (AUC = 4080 ± 1489 control vs 1540±719 mg/dl h with ASP; P = 0.004 by RM ANOVA). In addition there were decreases in postprandial glucose and non-esterified fatty acid (NEFA) levels in response to ASP. CONCLUSION: These results are the first to report that ASP can increase food intake in rats and also enhance postprandial TG clearance in obese animals. These data therefore support previous in vitro evidence pointing to ASP as a regulator of lipid metabolism.

Original languageEnglish (US)
Pages (from-to)705-713
Number of pages9
JournalInternational Journal of Obesity
Volume25
Issue number5
DOIs
StatePublished - 2001

Fingerprint

acylation
acute effects
hyperlipidemia
Hyperlipidemias
food intake
Rodentia
rodents
Eating
Triglycerides
proteins
triacylglycerols
Intraperitoneal Injections
intraperitoneal injection
mice
Area Under Curve
des-Arg-(77)-complement C3a
Analysis of Variance
analysis of variance
Fats
injection

Keywords

  • Acylation stimulating protein
  • Adipose tissue
  • Complement C3a
  • Glucose
  • Non-esterified fatty acid
  • Triglyceride

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Public Health, Environmental and Occupational Health
  • Endocrinology
  • Food Science
  • Endocrinology, Diabetes and Metabolism

Cite this

Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents. / Saleh, J.; Blevins, J. E.; Havel, Peter J; Barrett, J. A.; Gietzen, D. W.; Cianflone, K.

In: International Journal of Obesity, Vol. 25, No. 5, 2001, p. 705-713.

Research output: Contribution to journalArticle

Saleh, J. ; Blevins, J. E. ; Havel, Peter J ; Barrett, J. A. ; Gietzen, D. W. ; Cianflone, K. / Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents. In: International Journal of Obesity. 2001 ; Vol. 25, No. 5. pp. 705-713.
@article{eb250bf6387a4850b9a279ff23a2ee40,
title = "Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents",
abstract = "BACKGROUND: In vitro studies have shown that acylation stimulating protein (ASP) stimulates triglyceride (TG) synthesis and storage in adipocytes. We have previously demonstrated that intraperitoneal (i.p.) injection of ASP in C57BL/6J mice accelerated TG clearance following an orally-administered fat load as well as reducing postprandial glucose levels. RESULTS: In the present study, we first examined the effect of i.p. and intracerebroventricular (i.c.v.) injection of ASP on food intake in Sprague - Dawley rats. Intraperitoneal injection resulted in a short-term increase in food intake (maximum increase 29.3{\%} within the first hour, P < 0.025) decreasing thereafter as compared to vehicle alone, i.c.v. Administration of a comparable dose of ASP resulted in a similar but delayed increase in food intake with a maximum at 2 - 4 h, suggesting that the actions of ASP are peripherally mediated. However, there was no significant difference in 24 h food intake with either i.p. or i.c.v. injection. We also examined the effects of ASP on TG clearance in two obese mouse strains with different metabolic profiles: ob/ob (C57BL/6J-Lepob) and db/db (C57BLKS/J-Leprdb). In a crossover design, the response to an oral fat load was determined with and without i.p. injection of exogenous ASP. In ob/ob mice, there was a 44{\%} greater clearance of postprandial TG (area under the curve (AUC) = 245±49 control vs 138±43 mg/dl h with ASP; P< 0.05 by RM ANOVA). The db/db mice showed a greater response, with a 62{\%} decrease in postprandial TG (AUC = 4080 ± 1489 control vs 1540±719 mg/dl h with ASP; P = 0.004 by RM ANOVA). In addition there were decreases in postprandial glucose and non-esterified fatty acid (NEFA) levels in response to ASP. CONCLUSION: These results are the first to report that ASP can increase food intake in rats and also enhance postprandial TG clearance in obese animals. These data therefore support previous in vitro evidence pointing to ASP as a regulator of lipid metabolism.",
keywords = "Acylation stimulating protein, Adipose tissue, Complement C3a, Glucose, Non-esterified fatty acid, Triglyceride",
author = "J. Saleh and Blevins, {J. E.} and Havel, {Peter J} and Barrett, {J. A.} and Gietzen, {D. W.} and K. Cianflone",
year = "2001",
doi = "10.1038/sj.ijo.0801613",
language = "English (US)",
volume = "25",
pages = "705--713",
journal = "International Journal of Obesity",
issn = "0307-0565",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents

AU - Saleh, J.

AU - Blevins, J. E.

AU - Havel, Peter J

AU - Barrett, J. A.

AU - Gietzen, D. W.

AU - Cianflone, K.

PY - 2001

Y1 - 2001

N2 - BACKGROUND: In vitro studies have shown that acylation stimulating protein (ASP) stimulates triglyceride (TG) synthesis and storage in adipocytes. We have previously demonstrated that intraperitoneal (i.p.) injection of ASP in C57BL/6J mice accelerated TG clearance following an orally-administered fat load as well as reducing postprandial glucose levels. RESULTS: In the present study, we first examined the effect of i.p. and intracerebroventricular (i.c.v.) injection of ASP on food intake in Sprague - Dawley rats. Intraperitoneal injection resulted in a short-term increase in food intake (maximum increase 29.3% within the first hour, P < 0.025) decreasing thereafter as compared to vehicle alone, i.c.v. Administration of a comparable dose of ASP resulted in a similar but delayed increase in food intake with a maximum at 2 - 4 h, suggesting that the actions of ASP are peripherally mediated. However, there was no significant difference in 24 h food intake with either i.p. or i.c.v. injection. We also examined the effects of ASP on TG clearance in two obese mouse strains with different metabolic profiles: ob/ob (C57BL/6J-Lepob) and db/db (C57BLKS/J-Leprdb). In a crossover design, the response to an oral fat load was determined with and without i.p. injection of exogenous ASP. In ob/ob mice, there was a 44% greater clearance of postprandial TG (area under the curve (AUC) = 245±49 control vs 138±43 mg/dl h with ASP; P< 0.05 by RM ANOVA). The db/db mice showed a greater response, with a 62% decrease in postprandial TG (AUC = 4080 ± 1489 control vs 1540±719 mg/dl h with ASP; P = 0.004 by RM ANOVA). In addition there were decreases in postprandial glucose and non-esterified fatty acid (NEFA) levels in response to ASP. CONCLUSION: These results are the first to report that ASP can increase food intake in rats and also enhance postprandial TG clearance in obese animals. These data therefore support previous in vitro evidence pointing to ASP as a regulator of lipid metabolism.

AB - BACKGROUND: In vitro studies have shown that acylation stimulating protein (ASP) stimulates triglyceride (TG) synthesis and storage in adipocytes. We have previously demonstrated that intraperitoneal (i.p.) injection of ASP in C57BL/6J mice accelerated TG clearance following an orally-administered fat load as well as reducing postprandial glucose levels. RESULTS: In the present study, we first examined the effect of i.p. and intracerebroventricular (i.c.v.) injection of ASP on food intake in Sprague - Dawley rats. Intraperitoneal injection resulted in a short-term increase in food intake (maximum increase 29.3% within the first hour, P < 0.025) decreasing thereafter as compared to vehicle alone, i.c.v. Administration of a comparable dose of ASP resulted in a similar but delayed increase in food intake with a maximum at 2 - 4 h, suggesting that the actions of ASP are peripherally mediated. However, there was no significant difference in 24 h food intake with either i.p. or i.c.v. injection. We also examined the effects of ASP on TG clearance in two obese mouse strains with different metabolic profiles: ob/ob (C57BL/6J-Lepob) and db/db (C57BLKS/J-Leprdb). In a crossover design, the response to an oral fat load was determined with and without i.p. injection of exogenous ASP. In ob/ob mice, there was a 44% greater clearance of postprandial TG (area under the curve (AUC) = 245±49 control vs 138±43 mg/dl h with ASP; P< 0.05 by RM ANOVA). The db/db mice showed a greater response, with a 62% decrease in postprandial TG (AUC = 4080 ± 1489 control vs 1540±719 mg/dl h with ASP; P = 0.004 by RM ANOVA). In addition there were decreases in postprandial glucose and non-esterified fatty acid (NEFA) levels in response to ASP. CONCLUSION: These results are the first to report that ASP can increase food intake in rats and also enhance postprandial TG clearance in obese animals. These data therefore support previous in vitro evidence pointing to ASP as a regulator of lipid metabolism.

KW - Acylation stimulating protein

KW - Adipose tissue

KW - Complement C3a

KW - Glucose

KW - Non-esterified fatty acid

KW - Triglyceride

UR - http://www.scopus.com/inward/record.url?scp=0035011251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035011251&partnerID=8YFLogxK

U2 - 10.1038/sj.ijo.0801613

DO - 10.1038/sj.ijo.0801613

M3 - Article

C2 - 11360154

AN - SCOPUS:0035011251

VL - 25

SP - 705

EP - 713

JO - International Journal of Obesity

JF - International Journal of Obesity

SN - 0307-0565

IS - 5

ER -